This topic contains a solution. Click here to go to the answer

Author Question: Which of the following sets of substituents are all o/p-directing in electrophilic aromatic ... (Read 164 times)

pane00

  • Hero Member
  • *****
  • Posts: 579
Which of the following sets of substituents are all o/p-directing in electrophilic aromatic substitution reactions?
   
  a.
  Cl, CH3, CN
   
  b.
  Br, OH, COCH3
   
  c.
  Cl, OH, CH3
   
  d.
  CN, NO2, COCH3

Question 2

Which of the following undergoes the most rapid acylation upon treatment with acetyl chloride and AlCl3?
   
  a.
  benzene
   
  b.
  toluene
   
  c.
  chlorobenzene
   
  d.
  1,4-dichlorobenzene



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rekilledagain

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

c

Answer to Question 2

b




pane00

  • Member
  • Posts: 579
Reply 2 on: Aug 23, 2018
Wow, this really help


Laurenleakan

  • Member
  • Posts: 309
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

For a complete list of videos, visit our video library